DRUG STATUS

To achieve the best results, it is important to follow these guidelines:

• Take with or without food: Dolutegravir can be taken with or without food, though it may be better tolerated when taken with food, especially for individuals with a sensitive stomach.
• Regular dosing: Take Dolutegravir at the same time each day to help establish a routine and ensure consistent blood levels of the medication.
• Do not miss doses: Skipping doses can reduce the effectiveness of the medication and lead to drug resistance. If you miss a dose, take it as soon as you remember, unless it’s almost time for the next dose. Never take two doses at once.
• Storage: Keep Dolutegravir in its original packaging at room temperature, away from moisture and heat.

Dolutegravir is an integrase strand transfer inhibitor (INSTI). It works by blocking the integrase enzyme, which is responsible for allowing HIV’s genetic material to integrate into the DNA of human cells. This step is essential for the virus to replicate and spread in the body.

By inhibiting this enzyme, Dolutegravir effectively prevents the virus from making new copies of itself, reducing the viral load (the amount of HIV in the blood) and helping to preserve the immune system. The reduction of viral load makes the virus harder to spread to others and helps to prevent the progression of HIV to AIDS.

Dolutegravir works best as part of a combination therapy that targets multiple steps in the HIV life cycle. It is commonly prescribed with other antiretroviral drugs (ARVs), each working at different points to combat the virus.

While Dolutegravir is generally well-tolerated, some people may experience side effects. Common side effects include:

• Headache
• Diarrhea
• Nausea
• Fatigue
• Insomnia
• Dizziness

In rare cases, more serious side effects may occur, such as:

• Liver problems: Symptoms may include jaundice (yellowing of the skin or eyes), dark urine, or persistent nausea and vomiting.
• Allergic reactions: Although uncommon, some individuals may experience severe allergic reactions such as rash, swelling, or difficulty breathing.
• Psychiatric effects: There have been reports of depression, anxiety, or suicidal thoughts in some patients using Dolutegravir, although these are rare.

If you experience any severe or unusual side effects, seek medical help immediately.

There are a few important warnings and precautions to consider when using Dolutegravir:

• Pregnancy: Dolutegravir is generally considered safe for use during pregnancy, but it should be used with caution. It is recommended that women who are pregnant or planning to become pregnant discuss the use of Dolutegravir with their healthcare provider.
• Hepatitis: If you have hepatitis (particularly Hepatitis B or C), Dolutegravir should be used with caution. Liver function should be monitored regularly.
• Kidney or liver problems: People with severe liver problems should not use Dolutegravir. Patients with mild to moderate liver problems should be monitored regularly.
• Drug resistance: Although Dolutegravir is effective in suppressing HIV, there is always the risk of drug resistance if the medication is not taken as prescribed or if drug interactions occur.

Dolutegravir may interact with certain medications, which can either increase the risk of side effects or reduce its effectiveness. Some common drug interactions include:

• Antacids or multivitamins: Medications containing calcium, iron, or magnesium (such as antacids or certain supplements) can reduce the absorption of Dolutegravir. It is recommended to take Dolutegravir either 2 hours before or 6 hours after taking these products.
• Other antiretrovirals: When taken with other antiretroviral medications, the effectiveness of Dolutegravir may be altered. For example, certain protease inhibitors (PIs) may require a dose adjustment.
• Carbamazepine, phenytoin: These medications, used for seizure disorders, can lower the effectiveness of Dolutegravir.
• Rifampin: This antibiotic used for tuberculosis may lower the blood levels of Dolutegravir.
• Other medications: Medications like St. John’s Wort, which is used for depression, may interfere with the action of Dolutegravir.

Always inform your healthcare provider about any medications, supplements, or herbal products you are currently taking to avoid potential interactions.

Adults:

• Typical dose: 50 mg once daily
• In combination therapy: Dolutegravir is often taken in combination with other HIV medications, depending on the treatment regimen prescribed by your doctor.

Children:

• Dosage for children is based on their weight and age. It is essential that pediatric patients are prescribed the correct dosage by a healthcare provider.

Dolutegravir is a prescription medication, meaning you will need a prescription from a healthcare provider to use it. It is important to work closely with your doctor to determine the best treatment plan, which may include Dolutegravir as part of a combination therapy regimen.

1. What is dolutegravir?

• Dolutegravir is an antiretroviral medication used to treat HIV infection; it is an integrase strand transfer inhibitor (INSTI).

2. How does dolutegravir work?

• It blocks HIV integrase, preventing viral DNA from integrating into the host genome and thereby stopping viral replication.

3. What conditions is dolutegravir used to treat?

• Primarily used to treat HIV-1 infection in adults, adolescents, and children (with approved weight/age thresholds).

4. How is dolutegravir administered?

• Orally as a single drug or as part of combination tablets; usually once daily for most patients.

5. What are common side effects of dolutegravir?

• Common side effects include insomnia, headache, weight gain, and gastrointestinal symptoms like nausea.

6. Are there serious side effects of dolutegravir?

• Rare but serious effects can include hypersensitivity reactions, liver enzyme elevations, and potential neural tube defect risk if taken at conception.

7. Can pregnant people take dolutegravir?

• Dolutegravir is used in pregnancy, but there is a known potential risk of neural tube defects if taken at conception; risks and benefits should be discussed with a clinician.

8. Does dolutegravir interact with other medications?

• Yes. It has clinically important interactions with certain antacids, polyvalent cation-containing products (e.g., calcium, iron), some anticonvulsants, rifampin (requires dose adjustment), and certain metabolic inducers/inhibitors.

9. Can dolutegravir be taken with food?

• Yes. Dolutegravir may be taken with or without food, though some formulations or combinations may have specific recommendations.

10. What monitoring is required while on dolutegravir?

• Routine viral load and CD4 monitoring, hepatic function tests as indicated, and monitoring for neuropsychiatric symptoms, weight changes, and potential drug interactions.

11. How quickly does dolutegravir reduce viral load?

• Many patients see significant viral load reduction within weeks; full suppression typically within several months when taken with other effective antiretrovirals.

12. Can dolutegravir be used for HIV pre-exposure or post-exposure prophylaxis?

• Dolutegravir is not typically used alone for PrEP; it is used in treatment regimens and sometimes in PEP regimens as part of combination therapy per guidelines.

13. Is resistance to dolutegravir common?

• Dolutegravir has a high barrier to resistance; resistance is less common compared with some other agents but can occur, especially with suboptimal regimens or adherence.

14. Can people with renal impairment take dolutegravir?

• Dolutegravir does not require dose adjustment for mild-to-moderate renal impairment; use in severe impairment should follow specific product guidance and concomitant agents’ considerations.

15. Can people with hepatic impairment take dolutegravir?

• No routine dose adjustment for mild-to-moderate hepatic impairment; caution and monitoring are advised in more severe hepatic disease per product labeling.

16. Does dolutegravir affect contraception or hormone therapies?

• Dolutegravir has limited interaction with most hormonal contraceptives, but always check specific contraceptive method and concomitant drugs for interactions.

17. How should missed doses of dolutegravir be handled?

• Take the missed dose as soon as remembered unless it’s near the next scheduled dose; do not double dose. Follow clinician guidance for specific regimens.

18. Is dolutegravir safe for children?

• Yes—certain dolutegravir formulations and doses are approved for children and adolescents above specific weights/ages; dosing is weight-based.

19. What should be discussed with a clinician before starting dolutegravir?

• Current medications (including OTC and supplements), pregnancy status or plans, liver/renal disease, allergy history, and prior antiretroviral treatment history.

20. Does dolutegravir cause weight gain?

• Weight gain has been reported with dolutegravir-containing regimens; the magnitude varies and should be monitored alongside lifestyle and metabolic parameters.